Deepa V Cherla1, Maya L Moses2, Krislynn M Mueck3, Craig Hannon2, Tien C Ko2, Lillian S Kao3, Mike K Liang3. 1. Department of Surgery, University of Texas Health Science Center at Houston, Houston, TX; Center for Surgical Trials and Evidence-Based Practice, Houston, TX. Electronic address: cherladv@gmail.com. 2. Department of Surgery, University of Texas Health Science Center at Houston, Houston, TX. 3. Department of Surgery, University of Texas Health Science Center at Houston, Houston, TX; Center for Surgical Trials and Evidence-Based Practice, Houston, TX.
Abstract
BACKGROUND: The HERNIAscore is a ventral incisional hernia (VIH) risk assessment tool that uses only preoperative variables and predictable intraoperative variables. The aim of this study was to validate and modify, if needed, the HERNIAscore in an external dataset. STUDY DESIGN: This was a retrospective observational study of all patients undergoing resection for gastrointestinal malignancy from 2011 through 2015 at a safety-net hospital. The primary end point was clinical postoperative VIH. Patients were stratified into low-risk, medium-risk, and high-risk groups based on HERNIAscore. A revised HERNIAscore was calculated with the addition of earlier abdominal operation as a categorical variable. Cox regression of incisional hernia with stratification by risk class was performed. Incidence rates of clinical VIH formation within each risk class were also calculated. RESULTS: Two hundred and forty-seven patents were enrolled. On Cox regression, in addition to the 3 variables of the HERNIAscore (BMI, COPD, and incision length), earlier abdominal operation was also predictive of VIH. The revised HERNIAscore demonstrated improved predictive accuracy for clinical VIH. Although the original HERNIAscore effectively stratified the risk of an incisional radiographic VIH developing, the revised HERNIAscore provided a statistically significant stratification for both clinical and radiographic VIHs in this patient cohort. CONCLUSIONS: We have externally validated and improved the HERNIAscore. The revised HERNIAscore uses BMI, incision length, COPD, and earlier abdominal operation to predict risk of postoperative incisional hernia. Future research should assess methods to prevent incisional hernias in moderate-to-high risk patients.
BACKGROUND: The HERNIAscore is a ventral incisional hernia (VIH) risk assessment tool that uses only preoperative variables and predictable intraoperative variables. The aim of this study was to validate and modify, if needed, the HERNIAscore in an external dataset. STUDY DESIGN: This was a retrospective observational study of all patients undergoing resection for gastrointestinal malignancy from 2011 through 2015 at a safety-net hospital. The primary end point was clinical postoperative VIH. Patients were stratified into low-risk, medium-risk, and high-risk groups based on HERNIAscore. A revised HERNIAscore was calculated with the addition of earlier abdominal operation as a categorical variable. Cox regression of incisional hernia with stratification by risk class was performed. Incidence rates of clinical VIH formation within each risk class were also calculated. RESULTS: Two hundred and forty-seven patents were enrolled. On Cox regression, in addition to the 3 variables of the HERNIAscore (BMI, COPD, and incision length), earlier abdominal operation was also predictive of VIH. The revised HERNIAscore demonstrated improved predictive accuracy for clinical VIH. Although the original HERNIAscore effectively stratified the risk of an incisional radiographic VIH developing, the revised HERNIAscore provided a statistically significant stratification for both clinical and radiographic VIHs in this patient cohort. CONCLUSIONS: We have externally validated and improved the HERNIAscore. The revised HERNIAscore uses BMI, incision length, COPD, and earlier abdominal operation to predict risk of postoperative incisional hernia. Future research should assess methods to prevent incisional hernias in moderate-to-high risk patients.
Authors: Zachary M Borab; Sameer Shakir; Michael A Lanni; Michael G Tecce; John MacDonald; William W Hope; John P Fischer Journal: Surgery Date: 2016-12-28 Impact factor: 3.982
Authors: K Itatsu; Y Yokoyama; G Sugawara; H Kubota; Y Tojima; Y Kurumiya; H Kono; H Yamamoto; M Ando; M Nagino Journal: Br J Surg Date: 2014-08-14 Impact factor: 6.939
Authors: Christopher J Goodenough; Tien C Ko; Lillian S Kao; Mylan T Nguyen; Julie L Holihan; Zeinab Alawadi; Duyen H Nguyen; Juan R Flores; Nestor T Arita; J Scott Roth; Mike K Liang Journal: J Am Coll Surg Date: 2015-01-02 Impact factor: 6.113
Authors: Matthew C Christie; Jules P Manger; Abdulaziz M Khiyami; Afshan A Ornan; Karen M Wheeler; Noah S Schenkman Journal: J Endourol Date: 2015-10-20 Impact factor: 2.942
Authors: J Cornish; R L Harries; D Bosanquet; B Rees; J Ansell; N Frewer; P K Dhruva Rao; C Parry; R Ellis-Owen; S M Phillips; C Morris; J Horwood; M L Davies; M M Davies; R Hargest; Z Davies; J Hilton; D Harris; A Ben-Sassi; R Rajagopal; D Hanratty; S Islam; A Watkins; N Bashir; S Jones; I R Russell; J Torkington Journal: Trials Date: 2016-09-15 Impact factor: 2.279
Authors: Phoebe B McAuliffe; Abhishek A Desai; Ankoor A Talwar; Robyn B Broach; Jesse Y Hsu; Joseph M Serletti; Tiange Liu; Yubing Tong; Jayaram K Udupa; Drew A Torigian; John P Fischer Journal: Ann Surg Date: 2022-07-15 Impact factor: 13.787
Authors: E E Lozada-Hernández; J C Mayagoitía-González; R L Smolinski-Kurek; L Montiel-Hinojosa; L Hernández-Villegas; J M Morales-Vargas; K D Pérez-Sánchez; A Orozco-Mosqueda; M Cano-Rosas Journal: Hernia Date: 2021-01-05 Impact factor: 4.739
Authors: Núria Argudo; Miguel Pera; Manuel López-Cano; Lourdes Hernández; Juan José Sancho; Luis Grande; José Antonio Pereira Journal: Front Surg Date: 2018-02-16